//
Yu-hong Li
Wenqi Jiang
Fenghua Wang
Guo-ping Sun
Jianhua Chen
Lin Ying Cheng
Wei Liu
Rong-sheng Zheng
Jia Chen
Helong Zhang
Hai-tao Lan
Jun Qi
Yang-qing Liu
Yan-ming Deng
Heng Zhao
Jian ping Xiong
Qing Xu
Department of Breast Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China
Department of Oncology, The First Affiliated Hospital of An Hui Medical University, Hefei, China
Hunan Cancer Hospital, Changsha, China
Cancer Hospital of Shantou University Medical College, Shantou, China
Breast canter, Fourth Hospital of Hebei Medical University, Shijiazhuang, China
Anhui Provincial Cancer Hospital, Hefei, China
Jiangsu Cancer Hospital, Nanjing, China
Xijing Hospital, The Fourth Military Medical University, Xi'an, China
Sichuan Provincial People's Hospital, Chengdu, China
Chongqing Cancer Hospital, Chongqing, China
Huai'an First People's Hospital, Huaian, China
The First People's Hospital, Foshan City, Foshan, China
Shanghai Jiaotong University, Shanghai, China
The First Affiliated Hospital of Nanchang University, Nanchang, China
Shanghai the 6th Peoples Hospital, Shanghai, China
China
N/A
Oncology (ONC)
Esophageal squamous carcinoma cell
TNF Receptor Superfamily Member 1B
Fluorouracil
Adrucil injection
Cisplatin
N/A
Randomized
Multicenteric
Controlled
II
N/A
N/A
Final